Gilead Sciences Acquires CymaBay, For Approximately $4.3 Billion

Magnachip Semiconductor Corp Is A Hold Opportunity While Insiders Buy

Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues

Magnachip Semiconductor: An Intriguing Stock On A Bad Streak

Intel: CEO Gelsinger Fulfilling The Goals While Reducing Uncertainty

Sensor Tower Acquires data.ai

Francisco Partners to Buy Jama Software, For $1.2 Billion

2024’s Best & Worst States for Doctors – WalletHub Study

ceτi AI Announces Successful Launch of Revolutionary Decentralized AI Infrastructure Token

Credo Technology: Concentration Risk Still Overshadows Hyperscaler Progress

Pfizer: It’s Darkest Before The Dawn, Upgrading To ‘Strong Buy’

RestorePoint.AI Partners with Alkira

Amazon Stock May Be The Cheapest Mega Cap Right Now

Progress Software’s Balance Sheet Weakness Stands Out, But The Stock Looks Undervalued

2024’s Most Overweight and Obese Cities in the U.S. – WalletHub Study

Rakuten Medical Closes $119M Series E